Efficacy and Treatment Persistence of First line Natalizumab vs Interferon beta or Glatiramer Acetate in relapsing MS

---

BUTZKUEVEN H., SPELMAN T., KALİNCİK T., JOKUBAİTİS V., ZHANQ A., PELLEGRİNİ F., ...Daha Fazla

8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS), 19 - 21 Kasım 2015

• Yayın Türü: Bildiri
• Ondokuz Mayıs Üniversitesi Adresli: Evet